XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 47.78%860.73M | ---- | 23.21%582.43M | ---- | 19.40%472.73M | ---- | -4.52%395.91M | ---- | 15.32%414.63M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 13.80%-68.12M | ---- | 4.03%-79.03M | ---- | -12.17%-82.34M | ---- | -20.76%-73.41M | ---- | -9.17%-60.79M |
Dividend (income)- adjustment | ---- | -752.37%-3.96M | ---- | 9.20%-464K | ---- | 66.51%-511K | ---- | -134.77%-1.53M | ---- | 63.69%-650K |
Attributable subsidiary (profit) loss | ---- | 76.63%-756K | ---- | ---3.24M | ---- | ---- | ---- | ---- | ---- | 560.69%3.83M |
Impairment and provisions: | ---- | -13.36%117.15M | ---- | 43.99%135.22M | ---- | 52.08%93.91M | ---- | 128.41%61.75M | ---- | 305.49%27.03M |
-Impairmen of inventory (reversal) | ---- | 30.87%43.64M | ---- | 100.37%33.34M | ---- | 183.93%16.64M | ---- | 205.90%5.86M | ---- | -71.26%1.92M |
-Impairment of goodwill | ---- | ---- | ---- | 0.12%7.68M | ---- | --7.67M | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -21.95%73.52M | ---- | 35.35%94.19M | ---- | 24.52%69.59M | ---- | 122.50%55.89M | ---- | --25.12M |
Revaluation surplus: | ---- | -13.66%34.72M | ---- | 1,872.10%40.21M | ---- | ---2.27M | ---- | ---- | ---- | 60.16%-839K |
-Other fair value changes | ---- | -13.66%34.72M | ---- | 1,872.10%40.21M | ---- | ---2.27M | ---- | ---- | ---- | 60.16%-839K |
Asset sale loss (gain): | ---- | 985.88%5.27M | ---- | -34.31%-595K | ---- | -309.95%-443K | ---- | 427.50%211K | ---- | 118.96%40K |
-Loss (gain) on sale of property, machinery and equipment | ---- | 985.88%5.27M | ---- | -34.31%-595K | ---- | -309.95%-443K | ---- | 427.50%211K | ---- | 118.96%40K |
Depreciation and amortization: | ---- | 3.68%276.81M | ---- | 21.79%267M | ---- | 3.11%219.22M | ---- | 6.96%212.61M | ---- | 30.70%198.78M |
-Amortization of intangible assets | ---- | -5.32%156.34M | ---- | 26.69%165.13M | ---- | -5.21%130.34M | ---- | 10.93%137.51M | ---- | 34.48%123.96M |
Financial expense | ---- | 16.92%131.53M | ---- | 13.33%112.5M | ---- | 3.12%99.27M | ---- | 11.26%96.26M | ---- | 45.18%86.52M |
Special items | ---- | 251.52%7.4M | ---- | --2.1M | ---- | ---- | ---- | --3.81M | ---- | ---- |
Operating profit before the change of operating capital | ---- | 28.84%1.36B | ---- | 32.09%1.06B | ---- | 14.94%799.56M | ---- | 4.05%695.62M | ---- | 26.25%668.56M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -7.35%-117.8M | ---- | 77.54%-109.74M | ---- | -1,023.28%-488.62M | ---- | 243.05%52.92M | ---- | -108.89%-37M |
Accounts receivable (increase)decrease | ---- | 56.04%-198.19M | ---- | -91.62%-450.82M | ---- | 64.06%-235.27M | ---- | -20.37%-654.69M | ---- | -930.52%-543.88M |
Accounts payable increase (decrease) | ---- | -24.78%316.69M | ---- | 61.68%421.03M | ---- | 118.32%260.41M | ---- | -83.31%119.28M | ---- | 461.71%714.5M |
prepayments (increase)decrease | ---- | 1,268.51%109.95M | ---- | 106.62%8.03M | ---- | -217.13%-121.38M | ---- | 124.04%103.63M | ---- | ---431.17M |
Special items for working capital changes | ---- | 933.79%149.43M | ---- | -82.77%14.46M | ---- | 223.90%83.89M | ---- | 54.58%-67.71M | ---- | 64.72%-149.07M |
Cash from business operations | -82.75%47.71M | 72.60%1.62B | 338.57%276.65M | 214.50%939.1M | 58.23%-115.96M | 19.90%298.6M | -40.26%-277.65M | 12.21%249.05M | -193.02%-197.95M | 35.58%221.95M |
China income tax paid | ---- | ---- | ---- | ---- | -60.60%-42.95M | ---- | 6.06%-26.74M | ---- | 41.25%-28.47M | ---- |
Other taxs | -88.69%-133.14M | -64.85%-123.73M | ---70.56M | -62.73%-75.06M | ---- | 24.58%-46.12M | ---- | 11.77%-61.16M | ---- | -286.57%-69.32M |
Interest paid - operating | ---- | 34.15%-536K | ---- | 4.46%-814K | ---- | -42.71%-852K | ---- | -74.05%-597K | ---- | ---343K |
Net cash from operations | -141.45%-85.43M | 73.37%1.5B | 229.69%206.08M | 243.06%863.23M | 47.79%-158.91M | 34.35%251.62M | -34.43%-304.39M | 22.99%187.29M | -95.17%-226.42M | 4.47%152.28M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -17.13%68.12M | ---- | -1.62%82.2M | ---- | 30.80%83.55M | ---- | -10.93%63.88M | ---- | 16.99%71.72M |
Dividend received - investment | ---- | 752.37%3.96M | ---- | -9.20%464K | ---- | -66.51%511K | ---- | 134.77%1.53M | ---- | -63.69%650K |
Loan receivable (increase) decrease | ---- | --0 | ---- | --20M | ---- | --0 | ---- | -99.71%150K | ---- | -27.01%51M |
Decrease in deposits (increase) | -31.59%154.69M | 129.89%91.49M | 1,391.11%226.13M | -44.39%-306.13M | -69.56%-17.51M | 29.92%-212.02M | 94.30%-10.33M | -3,350.49%-302.56M | -367.63%-181.19M | 218.09%9.31M |
Sale of fixed assets | ---- | -67.79%6.47M | ---- | 221.36%20.07M | ---- | 80.68%6.25M | ---- | 575.20%3.46M | ---- | -83.74%512K |
Purchase of fixed assets | 21.75%-198.71M | -81.17%-446.29M | -223.27%-253.95M | -13.70%-246.34M | 17.86%-78.55M | -120.59%-216.65M | -212.88%-95.63M | -59.83%-98.22M | -45.87%-30.56M | -1.96%-61.45M |
Purchase of intangible assets | -80.56%-83.27M | 17.51%-118.29M | 32.35%-46.12M | 11.90%-143.4M | 3.90%-68.17M | 0.25%-162.78M | 18.36%-70.93M | 5.33%-163.19M | 0.05%-86.88M | -23.75%-172.38M |
Acquisition of subsidiaries | ---- | -635.85%-37.97M | ---- | 88.40%-5.16M | ---- | ---44.48M | ---- | ---- | ---- | ---2.99M |
Recovery of cash from investments | --120M | -97.00%70M | ---- | -2.87%2.33B | ---- | 6,451.06%2.4B | 3,991.74%718.06M | -79.75%36.68M | -97.71%17.55M | -36.13%181.14M |
Cash on investment | -32.35%-360M | 93.70%-153.27M | -189.36%-272M | -4.91%-2.43B | 90.60%-94M | -2,313.42%-2.32B | -85.19%-1B | 3.87%-96.13M | 23.40%-540M | 74.52%-100M |
Other items in the investment business | -92.76%3.03M | ---- | -23.25%41.9M | ---- | -6.59%54.6M | ---- | 69.13%58.45M | ---- | 173.02%34.56M | 88.03%-13.18M |
Net cash from investment operations | -19.81%-364.25M | 23.95%-515.8M | -49.30%-304.03M | -46.61%-678.19M | 49.14%-203.64M | 16.56%-462.57M | 49.09%-400.38M | -1,454.41%-554.4M | -2,531.13%-786.53M | 83.73%-35.67M |
Net cash before financing | -359.10%-449.68M | 430.06%980.8M | 72.98%-97.95M | 187.72%185.04M | 48.56%-362.55M | 42.54%-210.95M | 30.42%-704.77M | -414.79%-367.1M | -594.24%-1.01B | 258.67%116.62M |
Cash flow from financing activities | ||||||||||
New borrowing | 25.48%1.68B | -4.52%2.51B | -13.72%1.34B | 2.33%2.63B | -3.43%1.55B | 27.46%2.57B | 62.20%1.61B | 18.09%2.02B | 20.20%991.93M | 38.87%1.71B |
Refund | -19.38%-1.26B | 4.26%-2.67B | 23.66%-1.06B | -39.47%-2.79B | -36.12%-1.39B | -12.73%-2B | -30.87%-1.02B | -61.30%-1.78B | -104.41%-777.72M | -47.15%-1.1B |
Interest paid - financing | ---- | -17.29%-130.99M | ---- | -13.48%-111.69M | ---- | -2.87%-98.42M | ---- | -11.01%-95.67M | ---- | -44.60%-86.18M |
Dividends paid - financing | -25.06%-338.85M | -22.96%-273.52M | -23.89%-270.96M | -5.16%-222.46M | -3.39%-218.7M | 2.28%-211.54M | -482.75%-211.54M | 2.35%-216.48M | 78.46%-36.3M | -9.45%-221.69M |
Issuance expenses and redemption of securities expenses | ---- | 9.64%-141.95M | ---81.13M | ---157.1M | ---- | ---- | ---- | 96.00%-1.38M | ---- | -178.80%-34.58M |
Other items of the financing business | -164.93%-92.46M | 568.38%242.56M | 248.45%142.4M | -126.14%-51.79M | -457.47%-95.93M | -70.69%198.08M | -95.09%26.84M | 22,623.40%675.7M | 1,439.33%546.93M | ---3M |
Net cash from financing operations | -123.84%-16.05M | 33.22%-480.01M | 144.39%67.32M | -261.94%-718.77M | -137.78%-151.65M | -25.00%443.86M | -44.42%401.43M | 135.51%591.83M | 237.78%722.3M | 21.91%251.3M |
Effect of rate | -116.05%-1.6M | -72.79%6.18M | -12.39%9.96M | 405.43%22.71M | 627.13%11.37M | 61.56%-7.44M | -245.38%-2.16M | -319.52%-19.34M | 158.13%1.48M | -64.51%8.81M |
Net Cash | -1,420.40%-465.73M | 193.83%500.79M | 94.04%-30.63M | -329.16%-533.73M | -69.51%-514.2M | 3.64%232.91M | -4.37%-303.34M | -38.92%224.73M | -527.87%-290.64M | 177.37%367.92M |
Begining period cash | 29.86%2.2B | -23.13%1.7B | -23.13%1.7B | 11.37%2.21B | 11.37%2.21B | 11.55%1.98B | 11.55%1.98B | 26.88%1.78B | 26.88%1.78B | 12.66%1.4B |
Cash at the end | 3.60%1.74B | 29.86%2.2B | -1.69%1.68B | -23.13%1.7B | 1.68%1.71B | 11.37%2.21B | 12.70%1.68B | 11.55%1.98B | 1.51%1.49B | 26.88%1.78B |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | 30.87%4.85B | ---- | 43.70%3.71B | ---- | 14.34%2.58B | ---- | 26.85%2.26B | ---- | --1.78B |
Cash and cash equivalent balance | ---- | 30.87%4.85B | ---- | 43.70%3.71B | ---- | 14.34%2.58B | ---- | 26.85%2.26B | ---- | --1.78B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.